⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight
prnewswire.com
JNJ
MRK
TEVA
LLY
ABBV
PFE
AZN
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
businesswire.com
LLY
HUTCHMED Reports 2026 Interim Results
globenewswire.com
HCM
LLY
AZN
TMDX
Global Radiopharmaceutical CDMO Market to Accelerate Substantially at a CAGR of ~10% by 2034 | DelveInsight
globenewswire.com
TMO
MRK
DHR
LNT
THC
GEHC
NVS
LLY
AZN
Fraud Detection and Prevention (FDP) in BFSI Market worth $15.06 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MA
T
IBM
FIS
FISV
AXP
V
PYPL
COF
BK
BAC
JPM
WFC
C
MS
GS
SCHW
AXS
ALL
CB
PGR
TRV
UNM
MET
PRU
AIG
L
AIZ
SIGI
ENR
LNC
AGNC
IVZ
AMP
ICE
EQIX
AMZN
GOOGL
MSFT
NVDA
AMD
INTC
CSCO
ADBE
CRM
ORCL
SAP
ACN
GOOG
AMAT
MU
QCOM
TXN
INTU
ADP
PAYX
DXC
CTSH
INFY
WDC
SE
MELI
BABA
JD
NTES
PDD
BIDU
IQ
VIPS
XPEV
NIO
LI
LCID
RIVN
TSLA
GM
F
STLA
CHPT
BLNK
PLUG
FCEL
BE
RUN
SEDG
ENPH
CRSP
MRNA
BMY
PFE
JNJ
GILD
AMGN
BIIB
REGN
AZN
LLY
ABBV
XOM
CVX
SHEL
TTE
COP
EOG
APA
OXY
XNET
UPST
SOFI
HOOD
COIN
MP
EXAS
TDOC
ON
NXPI
MRVL
ALGN
IDXX
VRTX
SNPS
CDNS
MCHP
ADI
AVGO
LRCX
ASML
KLAC
TER
GPN
LXU
ACI
XPER
NICE
BCC
FEED
DV
Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
AZN
LLY
NVO
PFE
AMGN
BMY
JNJ
REGN
VKTX
ZETA
CRSP
IONS
AXSM
MRK
GSK
SNY
IMUX
BMEA
ALKS
ALT
AARD
NOV
CARM
CRIS
LPCN
GILD
REG
SPRO
ABSI
ALZN
ANVS
BV
ARCL
ACIU
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
globenewswire.com
SNY
LLY
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX